ETON
Eton Pharmaceuticals Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 4/10
- Momentum↑ 5/10
ETON Growth
- Revenue Y/Y↑ 97.91%
- EPS Y/Y↓ -18.18%
- FCF Y/Y↑ 897.34%
ETON Profitability
- Gross margin ↑ 51.90%
- EPS margin↓ -9.40%
- ROIC↓ -8.20%
ETON Risk
- Debt / Equity↓ 1.3
- Debt / FCF↓ 0.0
- Interest coverage↓ -0.7
Eton Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.